Merck, PATH Malaria Vaccine Initiative, New York University deal

PATH and Merck partnered with the university to develop a vaccine targeting Plasmodium falciparum circumsporozoite (CS) protein (CSP) to prevent malaria. PATH will provide financial support, Merck wi...